Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Performance and Lesion Evaluation of Neurothrombectomy Using CEREGLIDE 92 Intermediate Catheter: A Prospective Multi-Center Single-Arm IDE Trial (SPLENDID)

NCT06386289 is registered in ClinicalTrials.gov with Cerenovus, Part of DePuy Synthes Products, Inc. as lead sponsor.

NCT NCT06386289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06386289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Performance and Lesion Evaluation of Neurothrombectomy Using CEREGLIDE 92 Intermediate Catheter: A Prospective Multi-Center Single-Arm IDE Trial (SPLENDID)
Lead sponsor
Cerenovus, Part of DePuy Synthes Products, Inc.
Phase
Not applicable
Overall status
Withdrawn
Start date
September 1, 2025
Completion date
June 30, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke